Melanoma is a malignant neoplasm that originates from melanocytes. It continues to pose a significant challenge in oncology due to its aggressive nature and …
Cannabidiol as a Prophylactic Agent Against Glioblastoma Growth: A Preclinical Investigation.
Glioblastoma (GBM) remains one of the most lethal brain tumors, with current therapies offering limited benefits and high relapse rates. This study presents …
Medical marijuana for management of cancer pain: a narrative review.
The increasing legalization of medical marijuana in the United States (US) has spurred ongoing interest in its clinical application for the management of can…
Hemp-Derived Extracellular Vesicles: A Novel Frontier in Nanomedicine and Therapeutics.
While mammalian-derived extracellular vesicles (EVs) face significant challenges in clinical translation due to scalability, cost, and safety, plant-derived …
Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives.
This study aims to assess for indications of stigma and attitudes toward cannabis among cancer survivors (CS) who use or consider the use of cannabis. This s…
Leveraging the national cancer institute’s collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancer.
Cannabis use for symptom management among patients with cancer has increased significantly in recent years, with many reporting benefits for pain, anxiety, s…
‘The munchies’ are real and could benefit those with no appetite – MSN
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Appetite StimulationThcCachexiaOncologyEndocannabinoid System Why This MattersCannabis-induced appetite stimulation represents one of our most clinically...